In this study, our results showed that the increased CPAP expression in IL-6- and TNFα-treated human hepatocytes is mediated through SUMO-1 modification (Fig. 4E, F); our previous reports showed that the expression of CPAP mRNA increases during HCC progression [30, 31]. This evidence concerns the gene SUMO1 and hepatocellular carcinoma.